Big Data and Intellectual Property Rights in the Health and Life Sciences
Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
The vast prospects of Big Data and the shift to more “personalized”, “open” and “transparent” innovation models highlight the importance of an effective governance, regulation and stimulation of high-quality data-uses in the health and life sciences. Intellectual Property Rights (IPRs) and related rights come into play when research is translated into safe and efficient “real world” uses. While the need of recalibrating IPRs to fully support Big Data advances is being intensely debated among multiple stakeholders, there seems to be much confusion about the availability of IPRs and their legal effects. In this very brief presentation I intend to provide a very brief overview on the most relevant IPRs for data-based life science research. Realizing that the choice of how to address, use and interact with IPRs differs among various areas of applications, I also intend to sketch out and discuss selected areas that demonstrate emerging tensions and potential solutions at the interface of Big Data, Standardization and Intellectual Property Rights in the Health and Life Sciences.
|Publication status||Published - 2016|
|Event||Legal dimensions of Big Data in the Health and Life Sciences: -From intellectual property rights and global pandemics to privacy and ethics - CIIR, Copenhagen, Denmark|
Duration: 20 May 2016 → 20 May 2016
|Conference||Legal dimensions of Big Data in the Health and Life Sciences|
|Period||20/05/2016 → 20/05/2016|